Avlar BioVentures
Venture capitalMadingley · Series A–Growth
Frequently asked questions
- What stage does Avlar BioVentures invest at?
- Avlar BioVentures invests at the Series A, Series B, Series C, Growth stages.
- What sectors does Avlar BioVentures focus on?
- Avlar BioVentures focuses on Biotech, Healthtech, IoT, Medical Devices.
- Where is Avlar BioVentures located?
- Avlar BioVentures is headquartered in Madingley, GB.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Ambix is a healthcare-focused investment firm that provides funding, strategy, and hands-on support to companies developing medical tools and devices, biochemistry-based technologies, digital health applications, and other novel healthcare solutions. It invests across all stages and also builds companies itself.
MDI Ventures is the corporate venture capital arm of Indonesia's Telkom Group, investing in technology startups and emphasizing measurable social and environmental impact alongside financial returns.
M Ventures is the corporate venture arm of Merck KGaA based in Darmstadt, Germany, operating from offices in Amsterdam, the US, and Israel. The firm invests globally across early-stage companies and spin-offs in areas aligned with Merck's core business, taking active roles in portfolio company development.
Montis Capital is a Warsaw-based venture capital fund investing in teams with scalable, market-validated products in Industry 4.0 and life science sectors.